Patent · US Active

Process for making substituted quinazoline compounds

US9890128B2 · kind B2 · utility

0Cited by

4References

16Claims

0Family size

Assignees

Merck Sharp & Dohme LLC · US
AICURIS ANTI-INFECTIVE CURES AG · DE

Inventors

Michael R. Luzung · Jersey City, US
Guy R. Humphrey · Fryeburg, US
Bangping Xiang · Bound Brook, US
Kevin M. Belyk · Metuchen, US
Stephen M. Dalby · Hertford, GB
Wilfried Schwab · Altentreptow, DE
Burkhard Klenke · Wuppertal, DE
Tom Moody · Armagh, GB
Gareth Brown · Antrim, GB

Key dates

Filing date	Dec 8, 2014
Grant date	Feb 13, 2018
Priority date	—
Expiry date	Dec 8, 2034

Classification

Technology area (CPC B)Performing Operations; Transporting
CPC primaryB01J2231/324
WIPO fieldChemical engineering
WIPO sectorChemistry

Abstract

The present invention is directed to a process for making Substituted Quinazoline Compounds of formula (I): which are useful for the treatment and prophylaxis of HCMV infection. The present invention is also directed to compounds that are useful as synthetic intermediates for making the compounds of formula (I).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.